Clinical Trials Directory

Trials / Completed

CompletedNCT05642754

Glassy Trial for Effects of Wearing Glasses

Communicating Uncertainty About the Effects of Wearing Glasses to Reduce the Chance of Getting COVID (Corona Virus Disease): Protocol for a Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
960 (actual)
Sponsor
Trustees of Dartmouth College · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Randomized trial testing 6 forms of a communication summarizing the results of a recent study (about the effects of wearing glasses on reducing covid infection risk). The goal of the trial is to test the effect of different language options to describe uncertainty, and of including the margin of error around the main result.

Detailed description

The study is designed as a proof-of-concept exercise to develop and test a communication meant to summarize the results of a recent randomized trial examining the effects of wearing glasses on the chance of developing COVID-19. The objectives of the randomized trial are: * To compare the effects of three ways of communicating the overall uncertainty of the effects of wearing glasses to reduce the chance of getting COVID and * To compare the effects of including the margin of error (confidence interval) compared to not including it. Researchers will conduct an online, parallel group, individually randomized, pragmatic trial using a 3x2 factorial design, ie, 3 uncertainly language options (GRADE language, colloquial language or none 2 options for the statistical margin of error for the main results (margin of error language or none).

Conditions

Interventions

TypeNameDescription
OTHEROverall uncertainty languageResearchers are testing different forms of information about overall study uncertainty and margin of error around main result

Timeline

Start date
2022-12-01
Primary completion
2023-01-31
Completion
2023-03-31
First posted
2022-12-08
Last updated
2024-05-22

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05642754. Inclusion in this directory is not an endorsement.